West Pharmaceutical [WST] vs Hologic [HOLX] Detailed Stock Comparison

West Pharmaceutical

NYSE

Hologic

NASDAQ

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: West Pharmaceutical wins in 8 metrics, Hologic wins in 11 metrics, with 0 ties. Hologic appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	West Pharmaceutical	Hologic	Better
P/E Ratio (TTM)	35.69	27.76	Hologic
Price-to-Book Ratio	5.85	3.07	Hologic
Debt-to-Equity Ratio	10.52	52.09	West Pharmaceutical
PEG Ratio	31.70	14.17	Hologic
EV/EBITDA	21.54	12.43	Hologic
Profit Margin (TTM)	16.48%	13.79%	West Pharmaceutical
Operating Margin (TTM)	20.87%	25.48%	Hologic
EBITDA Margin (TTM)	20.87%	25.48%	Hologic
Return on Equity	17.72%	11.38%	West Pharmaceutical
Return on Assets (TTM)	10.53%	6.69%	West Pharmaceutical
Free Cash Flow (TTM)	$276.40M	$1.15B	Hologic
Dividend Yield	0.38%	N/A	N/A
1-Year Return	-16.28%	-18.63%	West Pharmaceutical
Price-to-Sales Ratio (TTM)	5.79	3.68	Hologic
Enterprise Value	$17.00B	$15.52B	West Pharmaceutical
EV/Revenue Ratio	5.74	3.84	Hologic
Gross Profit Margin (TTM)	35.73%	56.32%	Hologic
Revenue per Share (TTM)	$41	$18	West Pharmaceutical
Earnings per Share (Diluted)	$6.68	$2.41	West Pharmaceutical
Beta (Stock Volatility)	1.05	0.49	Hologic

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

West Pharmaceutical vs Hologic Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
West Pharmaceutical	0.18%	0.72%	9.30%	12.22%	-25.65%	-26.62%
Hologic	0.19%	1.34%	4.87%	21.15%	4.32%	-5.13%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
West Pharmaceutical	-16.28%	-29.33%	-11.56%	305.76%	1,336.11%	1,710.52%
Hologic	-18.63%	-6.75%	1.87%	60.33%	361.11%	493.89%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

West Pharmaceutical (WST): View Full Stock Overview

Hologic (HOLX): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: West Pharmaceutical vs Hologic

Metric	WST	HOLX
Market Information
Market Cap i	$17.14B	$14.88B
Market Cap Category	Large cap	Large cap
10 Day Avg. Volume i	1,122,987	1,830,700
90 Day Avg. Volume i	813,336	1,903,103
Last Close	$240.98	$68.06
52 Week Range	$187.43 - $352.33	$51.90 - $84.67
% from 52W High	-31.60%	-19.62%
All-Time High	$475.35 (Sep 06, 2021)	$87.88 (May 01, 2023)
% from All-Time High	-49.30%	-22.55%
Growth Metrics
Quarterly Revenue Growth	0.09%	0.01%
Quarterly Earnings Growth	0.18%	0.00%
Financial Health
Profit Margin (TTM) i	0.16%	0.14%
Operating Margin (TTM) i	0.21%	0.25%
Return on Equity (TTM) i	0.18%	0.11%
Debt to Equity (MRQ) i	10.52	52.09
Cash & Liquidity
Book Value per Share (MRQ)	$40.74	$21.79
Cash per Share (MRQ)	$7.09	$8.47
Operating Cash Flow (TTM) i	$676.70M	$1.07B
Levered Free Cash Flow (TTM) i	$207.85M	$760.11M
Dividends
Last 12-Month Dividend Yield i	0.38%	N/A
Last 12-Month Dividend i	$0.83	N/A

Valuation & Enterprise Metrics Analysis: West Pharmaceutical vs Hologic

Metric	WST	HOLX
Price Ratios
P/E Ratio (TTM) i	35.69	27.76
Forward P/E i	31.70	14.17
PEG Ratio i	31.70	14.17
Price to Sales (TTM) i	5.79	3.68
Price to Book (MRQ) i	5.85	3.07
Market Capitalization
Market Capitalization i	$17.14B	$14.88B
Enterprise Value i	$17.00B	$15.52B
Enterprise Value Metrics
Enterprise to Revenue i	5.74	3.84
Enterprise to EBITDA i	21.54	12.43
Risk & Other Metrics
Beta i	1.05	0.49
Book Value per Share (MRQ) i	$40.74	$21.79

Financial Statements Comparison: West Pharmaceutical vs Hologic

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	WST	HOLX
Revenue/Sales i	$766.50M	$1.01B
Cost of Goods Sold i	$492.60M	$628.00M
Gross Profit i	$273.90M	$377.30M
Research & Development i	$19.10M	$61.50M
Operating Income (EBIT) i	$158.90M	$37.90M
EBITDA i	$203.40M	$121.70M
Pre-Tax Income i	$157.00M	$-28.50M
Income Tax i	$30.20M	$-11.10M
Net Income (Profit) i	$131.80M	$-17.40M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	WST	HOLX
Cash & Equivalents i	$509.70M	$1.43B
Total Current Assets i	$1.68B	$3.21B
Total Current Liabilities i	$604.60M	$989.70M
Long-Term Debt i	$282.40M	$2.47B
Total Shareholders Equity i	$2.93B	$4.62B
Retained Earnings i	$4.14B	$3.03B
Property, Plant & Equipment i	$3.28B	$939.80M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	WST	HOLX
Operating Cash Flow i	$177.40M	$28.40M
Capital Expenditures i	N/A	$-24.70M
Free Cash Flow i	$101.90M	$129.20M
Debt Repayment i	$-300,000	$-10.20M
Common Stock Repurchase i	$-500,000	$-200.00M

Short Interest & Institutional Ownership Analysis

Metric	WST	HOLX
Shares Short i	1.83M	5.15M
Short Ratio i	2.92	2.16
Short % of Float i	0.03%	0.03%
Average Daily Volume (10 Day) i	1,122,987	1,830,700
Average Daily Volume (90 Day) i	813,336	1,903,103
Shares Outstanding i	72.30M	231.73M
Float Shares i	71.39M	220.31M
% Held by Insiders i	0.01%	0.01%
% Held by Institutions i	0.98%	1.04%

Dividend Analysis & Yield Comparison: West Pharmaceutical vs Hologic

Metric	WST	HOLX
Last 12-Month Dividend i	$0.83	N/A
Last 12-Month Dividend Yield i	0.38%	N/A
3-Year Avg Annual Dividend i	$0.79	N/A
3-Year Avg Dividend Yield i	0.07%	N/A
3-Year Total Dividends i	$2.37	N/A
Ex-Dividend Date	Apr 30, 2025	N/A

West Pharmaceutical [WST] vs Hologic [HOLX] Detailed Stock Comparison